• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镓-68-奥曲肽PET/CT在生长抑素表达肿瘤的管理中优于CT:非洲的首次经验。

Gallium-68-dotatate PET/CT is better than CT in the management of somatostatin expressing tumors: First experience in Africa.

作者信息

Lawal Ismaheel O, Ololade Kehinde O, Lengana Thabo, Reyneke Florette, Ankrah Alfred O, Ebenhan Thomas, Vorster Mariza, Sathekge Mike M

机构信息

Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.

出版信息

Hell J Nucl Med. 2017 May-Aug;20(2):128-133. doi: 10.1967/s002449910553. Epub 2017 Jul 12.

DOI:10.1967/s002449910553
PMID:28697189
Abstract

OBJECTIVE

In this study we aimed to present our experience on the use of Gallium-68-dotatate with positron emission tomography, computed tomography ( Ga-dotatate PET/CT) in the management of neuroendocrine tumors (NET) and other somatostatin expressing tumors.

SUBJECTS AND METHODS

We retrospectively reviewed patients with histologically confirmed or biochemically suspected NET and other somatostatin expressing (SSTR) tumors imaged at our department with Ga-dotatate PET/CT. We determined the performance of this imaging technique as well as its impact on patients management. A total of 203 patients were studied: 103 females, 100 males median age 52years.

RESULTS

The commonest tumor type was gastroenteropancreatic NET (41% of patients) and the commonest sites of distant metastases were lymph nodes and the liver 34.0% and 30.5% respectively. Positron emission tomography detected foci of disease in 19 patients where CT was falsely negative. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of Ga-dotatate PET/CT imaging of NET and other SST expressing tumors were 94.16%, 91.89%, 95.55%, 89.47% and 96.55% respectively.

CONCLUSION

Gallium-68-dotatate PET/CT was better than CT in detecting primary sites of the disease and highly sensitive and specific for diagnosis and treatment of NET and other SSTR expressing tumors.

摘要

目的

在本研究中,我们旨在介绍我们使用镓-68-奥曲肽正电子发射断层扫描、计算机断层扫描(镓-奥曲肽PET/CT)管理神经内分泌肿瘤(NET)和其他表达生长抑素的肿瘤的经验。

对象与方法

我们回顾性分析了在我院接受镓-奥曲肽PET/CT检查的组织学确诊或生化疑似NET及其他表达生长抑素(SSTR)肿瘤的患者。我们确定了这种成像技术的性能及其对患者管理的影响。共研究了203例患者:女性103例,男性100例,中位年龄52岁。

结果

最常见的肿瘤类型是胃肠胰神经内分泌肿瘤(占患者的41%),远处转移最常见的部位是淋巴结和肝脏,分别为34.0%和30.5%。正电子发射断层扫描在19例CT检查结果为假阴性的患者中检测到了病灶。镓-奥曲肽PET/CT对NET和其他表达SST的肿瘤成像的敏感性、特异性、阳性预测值、阴性预测值和准确性分别为94.16%、91.89%、95.55%、89.47%和96.55%。

结论

镓-68-奥曲肽PET/CT在检测疾病原发部位方面优于CT,对NET和其他表达SSTR的肿瘤的诊断和治疗具有高度敏感性和特异性。

相似文献

1
Gallium-68-dotatate PET/CT is better than CT in the management of somatostatin expressing tumors: First experience in Africa.镓-68-奥曲肽PET/CT在生长抑素表达肿瘤的管理中优于CT:非洲的首次经验。
Hell J Nucl Med. 2017 May-Aug;20(2):128-133. doi: 10.1967/s002449910553. Epub 2017 Jul 12.
2
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤患者中 68Ga-DOTANOC 与 68Ga-DOTATATE PET/CT 的比较。
J Nucl Med. 2013 Mar;54(3):364-72. doi: 10.2967/jnumed.112.111724. Epub 2013 Jan 7.
3
Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management.优化神经内分泌肿瘤患者的生长抑素受体显像:99mTc-HYNICTOC SPECT/SPECT/CT 与 68Ga-DOTATATE PET/CT 对临床管理的影响。
Clin Nucl Med. 2017 Dec;42(12):905-911. doi: 10.1097/RLU.0000000000001877.
4
MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Ga-DOTATATE and F-FDG and Multimodality Anatomic Imaging in Metastatic Neuroendocrine Tumors of Unknown Primary in a PRRT Workup Setting.在肽受体放射性核素治疗(PRRT)检查背景下,对镓-多柔比星(Ga-DOTATATE)和氟-氟代脱氧葡萄糖(F-FDG)双示踪剂PET/CT及多模态解剖成像进行MIB-1指数分层评估,用于不明原发灶的转移性神经内分泌肿瘤。
J Nucl Med Technol. 2017 Mar;45(1):34-41. doi: 10.2967/jnmt.116.185777. Epub 2017 Feb 2.
5
Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First U.S. Prospective, Reader-Masked Clinical Trial.^18^F-FDG PET/CT 与 ^68^Ga-DOTATATE PET/CT 在头颈部神经内分泌肿瘤诊断中的对比研究
J Nucl Med. 2020 Jun;61(6):890-896. doi: 10.2967/jnumed.119.236091. Epub 2020 Jan 10.
6
ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors.ACR 实践参数:用于神经内分泌肿瘤的镓-68 DOTATATE PET/CT 性能。
Clin Nucl Med. 2018 Dec;43(12):899-908. doi: 10.1097/RLU.0000000000002309.
7
The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumours.68Ga-DOTATATE PET/CT在神经内分泌肿瘤检测中的诊断作用。
Nucl Med Rev Cent East Eur. 2011;14(1):16-20. doi: 10.5603/nmr.2011.0004.
8
Head-to-Head Comparison of Cu-DOTATATE and Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors.铜-多靶点肽(Cu-DOTATATE)与镓-多靶点肽(Ga-DOTATOC)PET/CT的头对头比较:59例神经内分泌肿瘤患者的前瞻性研究。
J Nucl Med. 2017 Mar;58(3):451-457. doi: 10.2967/jnumed.116.180430. Epub 2016 Sep 22.
9
Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.(68)Ga-DOTATOC与(68)Ga-DOTATATE在胃肠胰神经内分泌肿瘤PET/CT中的摄取差异
Recent Results Cancer Res. 2013;194:353-71. doi: 10.1007/978-3-642-27994-2_18.
10
[Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT].[使用68Ga-DOTATATE PET/CT对神经内分泌肿瘤中生长抑素受体的免疫组化表达进行定量分析]
Radiologe. 2010 Apr;50(4):349-54. doi: 10.1007/s00117-009-1972-2.

引用本文的文献

1
Advances in Radioligand Theranostics in Oncology.肿瘤学中的放射性配体治疗学进展。
Mol Diagn Ther. 2024 May;28(3):265-289. doi: 10.1007/s40291-024-00702-4. Epub 2024 Mar 31.